My vision

Peerless Biotech Pvt. Ltd. has been growing well over the last four years, and our growth is an all-rounded growth. We are convinced, this growth has come to us only because we have been consistently fulfilling our responsibilities toward all our stakeholders.

We are not only customer oriented, but we also give due importance to all the stakeholders and we fulfil our responsibilities toward them without any compromise. We strongly believe, all our stakeholders are important.

After achieving a turnover of ₹144 crore in 2021-22, we have taken up a target of ₹200 crore for 2022-23. We are sure to overshoot this target. Our broad plans for 2027-28 are already prepared by us. In our journey toward excellence, we will cross the milestone of ₹500 crore in 2025-26.

For the first 20 years of our business, we focused only on the in-vitro diagnostics range of products. In 2021-22, we decided to move beyond in-vitro diagnostics and have already launched a separate division for home healthcare, wellness, and hospital products. In the years to come, this new segment of our business is expected to grow very rapidly.

However, in-vitro diagnostics segment will continue to contribute about 70 percent to 75 percent of our business volume, when we reach the turnover of ₹500 crore in 2025-26.

In 2021-22, we also established our manufacturing facility in Chennai to manufacture products of ACON, USA, with their brand name. With this, many of the products presently sold by us will get manufactured in India. We see our company’s future in manufacturing, and so we will focus on it.

Our research and development facility is an extension of our manufacturing facility in Chennai. We are presently building a team for development of in-vitro diagnostic kits and instruments.

In 2023-24, we will have our own online platform to promote our home healthcare and wellness products. We see a big scope for B2C online business for home healthcare and wellness products.

While we are growing, we see a lot of growth opportunities for our employees because we have always been giving preference to the talent from within. Presently, we are building our leadership pipeline in a planned way.

With a team of experienced professionals coming in, the operations of the company are already in the hands of the professionals. We are in the process of separating out the management from the ownership.

The board of directors of the company is being strengthened with industry experts, who will be non-executive directors. This professional board will play a crucial role in keeping the company on the right path. This board will guide the company for a wholesome, all-rounded, and inclusive growth.

We have plans to list our company on the SME platform at an appropriate time. We look at the listing of our company as the most important stage in the life of our company. This is because in the process of listing, we will get an opportunity to share with all our stakeholders the wealth, which we have created over the last several years. In the process of listing, opportunity-to-be-a-shareholder will be given to all those stakeholders of the company who have been supporting us in our growth.

With the CSR funds of the company, we are already supporting an old-age home. In the days to come, we are also getting ready to run an old-age home independently in Chennai. Rather than distributing our funds and our efforts on several projects, we will focus on supporting the aging and needy people in Chennai.

We are on our journey towards excellence. I invite all to join us in every possible way and be a part of our success story. In this journey toward excellence, there is a place for everyone in Peerless Biotech Pvt. Ltd., and there is a scope for everyone to contribute.